deltatrials
Completed NA INTERVENTIONAL 2-arm NCT02856269

Zinc Supplementation and Cardiovascular Risk in HIV

Sponsor: Grace McComsey

Interventions Zinc gluconate
Updated 12 times since 2017 Last updated: Feb 10, 2022 Started: Sep 30, 2016 Primary completion: Apr 16, 2018 Completion: Apr 16, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02856269, this NA trial focuses on HIV and Inflammation and remains completed. Sponsored by Grace McComsey, it has been updated 12 times since 2016, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Study Description(click to expand)

Zinc is a dietary supplement with compelling preclinical evidence for potential health benefit that could be expanded not only to the entire HIV population, but also to other inflammatory conditions that share many facets of HIV infection, namely the persistent intestinal barrier dysfunction, monocyte activation and heightened inflammation state.

Zinc is a dietary supplement with compelling preclinical evidence for potential health benefit that could be expanded not only to the entire HIV population, but also to other inflammatory conditions that share many facets of HIV infection, namely the persistent intestinal barrier dysfunction, monocyte activation and heightened inflammation state.

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshotNot Yet Recruiting~Aug 2017 – ~Jun 2018 · 10 months · monthly snapshotRecruiting~Jun 2018 – ~Nov 2018 · 5 months · monthly snapshotRecruiting~Nov 2018 – ~Jan 2021 · 26 months · monthly snapshotActive Not Recruiting~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotActive Not Recruiting~Oct 2021 – ~Mar 2022 · 5 months · monthly snapshotUnknown Status~Mar 2022 – ~Dec 2022 · 9 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 19 months · monthly snapshotCompleted~Jan 2026 – present · 3 months · monthly snapshotCompleted

Change History

12 versions recorded
  1. Jan 2026 — Present [monthly]

    Completed NA

  2. Sep 2024 — Present [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. Jan 2023 — Jul 2024 [monthly]

    Completed NA

  5. Dec 2022 — Jan 2023 [monthly]

    Completed NA

Show 7 earlier versions
  1. Mar 2022 — Dec 2022 [monthly]

    Completed NA

    Status: Unknown StatusCompleted

  2. Oct 2021 — Mar 2022 [monthly]

    Unknown Status NA

    Status: Active Not RecruitingUnknown Status

  3. Jan 2021 — Oct 2021 [monthly]

    Active Not Recruiting NA

  4. Nov 2018 — Jan 2021 [monthly]

    Active Not Recruiting NA

    Status: RecruitingActive Not Recruiting

  5. Jun 2018 — Nov 2018 [monthly]

    Recruiting NA

  6. Aug 2017 — Jun 2018 [monthly]

    Recruiting NA

    Status: Not Yet RecruitingRecruiting

  7. Jan 2017 — Aug 2017 [monthly]

    Not Yet Recruiting NA

    First recorded

Sep 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Grace McComsey
  • National Center for Complementary and Integrative Health (NCCIH)
Data source: University Hospitals Cleveland Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations